Update on bone health: the International Menopause Society White Paper 2021

Autor: Steven R. Goldstein, T. J. de Villiers

Publikováno v: Climacteric. 24:498-504

Osteoporosis and associated fractures present a major challenge in improving global health outcomes. Key clinical aspects are the definition of osteoporosis and associated fractures, fracture risk prediction, stratification of risk of fracture, inter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb15ba5142a57726dd7c767b01d0bbb4
https://doi.org/10.1080/13697137.2021.1950967

Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis

Autor: Annpey Pong, Bente L. Langdahl, T. J. de Villiers, Felicia Cosman, Andrew Denker, Arthur C. Santora, Kenneth G. Saag, Boyd B. Scott

Publikováno v: Saag, K, Cosman, F, De Villiers, T, Langdahl, B, Scott, B B, Denker, A E, Pong, A & Santora, A C 2021, ' Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates : a post hoc analysis ', Osteoporosis International, vol. 32, no. 9, pp. 1879-1888 . https://doi.org/10.1007/s00198-020-05785-3

Summary: This post hoc analysis of a randomized, double-blind study of postmenopausal women with osteoporosis found that there were early increases in bone turnover markers and decreases in bone mineral density after discontinuation of long-term alen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a93ead527927949a640378551e2db7a
https://doi.org/10.1007/s00198-020-05785-3

Effects of ospemifene on bone in postmenopausal women

Autor: M Particco, C Altomare, Marco Gambacciani, T. J. de Villiers

Publikováno v: Climacteric. 22:442-447

Ospemifene is a selective estrogen-receptor modulator approved for treating menopause-related moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy (VVA), in the United States, and for treating menopause-related, sympto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee697947fd2a09f124cd78ad16bca7d
https://doi.org/10.1080/13697137.2019.1631789

The quest for new drugs to prevent osteoporosis-related fractures

Autor: T. J. de Villiers

Publikováno v: Climacteric. 20:103-106

There is a need for the development of new drugs to prevent osteoporosis-related fractures. Fractures are projected to increase and the present drugs have modest efficacy, significant side-effects and poor compliance. To illustrate the difficulties i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba76c5a8b427bb7c2f95010d164b64f
https://doi.org/10.1080/13697137.2017.1289659

Bone management in hematologic stem cell transplant recipients

Autor: Jorge B. Cannata-Andía, M. L. Brandi, Jean-Jacques Body, M J Cannata-Ortiz, Giuseppe Guglielmi, Peter R. Ebeling, David L. Kendler, D. D. Pierroz, A. El Maghraoui, R Broady, T. J. de Villiers, René Rizzoli, Peyman Hadji, Bone Disease

Publikováno v: Osteoporosis International, Vol. 29, No 12 (2018) pp. 2597-2610

Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for patients with some malignant and non-malignant hematological diseases. Advances in transplantation techniques and supportive care measures have su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848ec55224f5251fd6f49ba77ec43f97
https://pubmed.ncbi.nlm.nih.gov/30178158